We found that JAK inhibitors decreased the viability and phosphorylation of STAT3-mutated NK cell lines and LGL leukemia patient samples in the presence of cytokines, indicating that STAT3 mutation alone does not confer high resistance to JAK inhibition in these conditions. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.